#161587

Plasmax™, Glucose-Free Cell Culture Medium

Cat. #161587

Plasmax™, Glucose-Free Cell Culture Medium

Cat. #: 161587

Sub-type: Cell culture media

Unit size: 500 ml

Availability: 3-5 days

Application: Cell culture; Cell growth and viability; Glucose starvation experiments; Cancer metabolism studies; Metabolic flux analysis

Volume: 500 ml

£120.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Saverio Tardito

Institute: CRUK Scotland Institute

Primary Citation: Vande Voorde et al. 2019. Sci Adv. 5(1):eaau7314. PMID: 30613774

Tool Details
Handling
Application Details
Related Tools
References
Documentation

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Tool name: Plasmax™, Glucose-Free Cell Culture Medium
  • Alternate name: Customised PlasmaxTM
  • Research fields: Cancer;Cell biology
  • Tool sub type: Cell culture media
  • Purpose: A tailored cell culture solution based on physiologically relevant cell culture medium which mimics the metabolic and physiological profile of human plasma
  • Formulation: PlasmaxTM cell culture media (Cat.# 156371) formulation without glucose. The PlasmaxTM cell culture media (Cat.# 156371) formulation can be found here.
  • Application: Cell culture; Cell growth and viability; Glucose starvation experiments; Cancer metabolism studies; Metabolic flux analysis

Handling

  • Format: Liquid
  • Volume: 500 ml
  • Storage conditions: Stable until expiry date on label

Application Details

  • Application: Cell culture; Cell growth and viability; Glucose starvation experiments; Cancer metabolism studies; Metabolic flux analysis
  • Application notes: The customised version of PlasmaxTM is created to fit your experiment’s unique requirements

Related Tools

  • Related tools: 156371

References

  • Bagshawet al. Mitochondrial Intoxication. 2023, 723-744
  • Gassl et al. Cancers (Basel) 2022 Nov 16,14(22):5617. PMID: 36428711
  • Wang et al. Biomolecules 2022 Oct 27,12(11):1575. PMID: 36358924
  • Villar et al. 2022. Nat Chem Biol. PMID: 36280791
  • Gardner et al. 2022. Am J Physiol Cell Physiol 323(3):C823-C834. PMID: 35876286
  • Golikov et al. 2022. Mol Biol (Mosk) 56(5):687-696. PMID: 36165010
  • Taurino et al. 2022. Mol Metab. 101532 PMID: 35752287
  • Wang et al. 2022. Biomolecules. 12(6):743. PMID: 35740868
  • Bagshaw et al. 2021. Biomaterials and Biosystems.4 (100027): 2666-5344
  • Golikov et al. 2022. Antioxidants 2022, 11, 97.
  • Golikov et al. Antioxidants 2022, 11(1), 97
  • Kalimuthu et al. 2021. J Cell Biochem. :. PMID: 34935169.
  • Hennequart et al. 2021. Nature Communications. 12: 6176.
  • Chiu et al. 2021. American Society of Hematology. Blood Advances.
  • Cox et al. 2020. Journal of Data and Information Science. 5(3): 161-177
  • Moradi et al. 2021. Biomolecules. 11(8): 1177
  • Plasmax Application Note
  • Barekatain et al. 2021. Nature. 12: 4228.
  • Moradi et al. 2021. American Journal of Physiology. Cell Physiology. 321 (1): C72-C81.
  • Khadka et al. 2021. Cancer & Metabolism. 9:27
  • Abbas et al. 2021. Comp Biochem Physiol B Biochem Mol Biol. 254:110570. PMID: 33516822.
  • PlasmaxTM: Product Brochure
  • Ackermann et al. 2019. Trends Cancer. 5(6):329-332. PMID: 31208694.
  • Cell culture shock – a scientist’s hunt for the perfect cocktail
  • Vande Voorde et al. 2019. Sci Adv. 5(1):eaau7314. PMID: 30613774.